Antiatherosclerotic therapy using cell differentiation-promoting effect of biologically active peptides

利用生物活性肽的细胞分化促进作用进行抗动脉粥样硬化治疗

基本信息

项目摘要

We first examined the expression of receptors for natriuretic peptides(ANP, BNP, CNP) in wire-injured femoral arteries in mice. Significant expressions of both GC-A(receptor for ANP and BNP) and GC-B(receptor for CNP) were found in neointima after 3 weeks of wire injury, and the expression level of GC-A was higher than that of GC-B. When the extent of wire injury-induced neointima formation was compared between wild-type and GC-A knockout mice, the area of neointima was greater in GC-A knockout mice. This result suggested the possibility that endogenous ANP and BNP released from the heart inhibited atherosclerotic change of femoral artery after wire injury. To further examine the role of endogenous ANP and BNP in neovascularization observed in atherosclerotic lesions, lower limb-ischemic model was made in both wild-type and GC-A knockout mice, and the recovery of blood flow was evaluated. The blood flow was restored to about 70% after 3 weeks in wild-type mice. On the other hand, inter … More estingly, the recovery rate of blood flow in GC-A knockout mice was about 20%, and approximately half of them had necrotized lower limbs. The finding suggested that endogenous ANP and BNP might play an important role in the angiogenesis in ischemic lesions. From these results, an in vitro study was designed to investigate whether ANP and BNP, stimulate cyclic GMP(cGMP) accumulation in vascular endothelial progenitor cells derived from human blood mononuclear cells. As a result, intracellular cGMP levels were remarkably elevated after stimulation with ANP and BNP, suggesting that these peptides have a direct effect on endothelial progenitor cells. Our findings indicate that endogenous ANP and BNP are involved not only in the inhibition of the formation of atherosclerotic lesions, but also in the promotion of neovascularization in those lesions. Thus, the present study provided a great progress forclinical application of antiatherosclerotic therapy using cell differentiation-promoting effect of ANP and BNP. We will forward further investigations about antiatherosclerotic effects and therapeutic application of CNP, adrenomedulin, and ghrelin. Less
我们首先检测了小鼠股动脉钢丝损伤后利钠肽受体(ANP、BNP、CNP)的表达。钢丝损伤3周后,新生内膜中GC-A(ANP和BNP受体)和GC-B(CNP受体)均有明显表达,且GC-A的表达水平高于GC-B。当在野生型和GC-A基因敲除小鼠之间比较导丝损伤诱导的新生内膜形成的程度时,GC-A基因敲除小鼠的新生内膜面积更大。提示心脏释放的内源性ANP和BNP可能抑制了钢丝损伤后股动脉的粥样硬化性改变。为了进一步研究内源性ANP和BNP在动脉粥样硬化病变中观察到的新血管形成中的作用,在野生型和GC-A基因敲除小鼠中制备下肢缺血模型,并评价血流的恢复。在野生型小鼠中,3周后血流量恢复到约70%。另一方面, ...更多信息 GC-A基因敲除小鼠血流量恢复率约为20%,约一半的小鼠出现下肢坏死。提示内源性ANP和BNP可能在缺血性血管新生中起重要作用。根据这些结果,设计体外研究以研究ANP和BNP是否刺激源自人血液单核细胞的血管内皮祖细胞中的环GMP(cGMP)积累。结果表明,ANP和BNP刺激后,细胞内cGMP水平显著升高,表明这些肽对内皮祖细胞具有直接作用。我们的研究结果表明,内源性ANP和BNP不仅参与抑制动脉粥样硬化病变的形成,而且还参与促进这些病变中的新生血管形成。因此,本研究为利用ANP和BNP的促细胞分化作用进行抗动脉粥样硬化治疗的临床应用提供了重要进展。我们将对CNP、肾上腺髓质素和生长素释放肽的抗动脉粥样硬化作用和治疗应用作进一步的研究。少

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
高血圧性心不全-病態と診断・治療の現状 高血圧性心不全とナトリウム利尿ホルモン
高血压性心力衰竭——病理、诊断和治疗现状 高血压性心力衰竭与利尿钠激素
  • DOI:
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    0
  • 作者:
    小山建一;各務博;堀尾武史
  • 通讯作者:
    堀尾武史
Exogenous ghrelin attenuates the progression of chronic hypoxic-induced pulmonary hypertension in conscious rats.
外源性生长素释放肽可减轻清醒大鼠慢性缺氧诱导的肺动脉高压的进展。
  • DOI:
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Daryl O. Schwenke;et. al.
  • 通讯作者:
    et. al.
高血圧性心不全とナトリウム利尿ホルモン
高血压心力衰竭和利尿钠激素
  • DOI:
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hidenori Nishida;et. al.;堀尾 武史
  • 通讯作者:
    堀尾 武史
慢性心不全治療の進歩-成因と臨床研究-心不全の発症進展機序 サイトカイン
慢性心力衰竭的治疗进展 - 病因和临床研究 - 心力衰竭的发病和进展机制 细胞因子
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yoshio Iwashima;et. al.;堀尾武史
  • 通讯作者:
    堀尾武史
Plasma adrenomedullin as an independent predictor of future cardiovascular events in hypertensive patients.
血浆肾上腺髓质素作为高血压患者未来心血管事件的独立预测因子。
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hidenori Nishida;et. al.
  • 通讯作者:
    et. al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HORIO Takeshi其他文献

HORIO Takeshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HORIO Takeshi', 18)}}的其他基金

Primary prevention of atrial fibrillation in hypertensive patients
高血压患者房颤的一级预防
  • 批准号:
    25461079
  • 财政年份:
    2013
  • 资助金额:
    $ 2.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
DNA damage and immunosuppressive cytokines induced by ultraviolet radiation and chemical carcinogen
紫外线和化学致癌物引起的DNA损伤和免疫抑制细胞因子
  • 批准号:
    14570830
  • 财政年份:
    2002
  • 资助金额:
    $ 2.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Treatment of Atopic Dermatitis with PUVA Photochemotherapy : Clinical and Experimental Studies in Patients and Model Mice
PUVA 光化疗治疗特应性皮炎:患者和模型小鼠的临床和实验研究
  • 批准号:
    11670854
  • 财政年份:
    1999
  • 资助金额:
    $ 2.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The relationship between DNA damage and immunosuppression by ultraviolet radiation
紫外线损伤DNA与免疫抑制的关系
  • 批准号:
    09670901
  • 财政年份:
    1997
  • 资助金额:
    $ 2.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Association of diuretics with change in extracellular volume, natriuretic peptides, symptoms, and cardiovascular outcomes in CKD
利尿剂与 CKD 细胞外容量、利尿钠肽、症状和心血管结局变化的关系
  • 批准号:
    10366684
  • 财政年份:
    2022
  • 资助金额:
    $ 2.49万
  • 项目类别:
Association of diuretics with change in extracellular volume, natriuretic peptides, symptoms, and cardiovascular outcomes in CKD
利尿剂与 CKD 细胞外容量、利尿钠肽、症状和心血管结局变化的关系
  • 批准号:
    10595584
  • 财政年份:
    2022
  • 资助金额:
    $ 2.49万
  • 项目类别:
Natriuretic Peptides Induce Thermogenesis and Improve Insulin Resistance
利钠肽诱导生热并改善胰岛素抵抗
  • 批准号:
    21K16099
  • 财政年份:
    2021
  • 资助金额:
    $ 2.49万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Clarification of the transcriptional regulatory mechanism of natriuretic peptides in failing hearts
澄清心衰中利尿钠肽的转录调节机制
  • 批准号:
    20K17151
  • 财政年份:
    2020
  • 资助金额:
    $ 2.49万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Association of diuretics with change in extracellular volume, natriuretic peptides, symptoms, and cardiovascular outcomes in CKD
利尿剂与 CKD 患者细胞外容量、利尿钠肽、症状和心血管结局变化的关系
  • 批准号:
    9890162
  • 财政年份:
    2020
  • 资助金额:
    $ 2.49万
  • 项目类别:
Role of central natriuretic peptides in invasion into freshwater environment
中枢利钠肽在入侵淡水环境中的作用
  • 批准号:
    20K15604
  • 财政年份:
    2020
  • 资助金额:
    $ 2.49万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The role of natriuretic peptides in sinoatrial node dysfunction and atrial fibrillation in hypertensive heart disease
利钠肽在高血压心脏病窦房结功能障碍和心房颤动中的作用
  • 批准号:
    401342
  • 财政年份:
    2019
  • 资助金额:
    $ 2.49万
  • 项目类别:
    Operating Grants
Development of heart failure home monitoring utilizing urinary natriuretic peptides
利用尿利钠肽进行心力衰竭家庭监测的开发
  • 批准号:
    19K20724
  • 财政年份:
    2019
  • 资助金额:
    $ 2.49万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Race, Natriuretic Peptides and Physiological Perturbations
种族、利尿钠肽和生理干扰
  • 批准号:
    10397576
  • 财政年份:
    2019
  • 资助金额:
    $ 2.49万
  • 项目类别:
Race, Natriuretic Peptides and Physiological Perturbations
种族、利尿钠肽和生理干扰
  • 批准号:
    10591601
  • 财政年份:
    2019
  • 资助金额:
    $ 2.49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了